Invention Grant
- Patent Title: Tinostamustine for use in the treatment of T-cell prolymphocytic leukaemia
-
Application No.: US17730276Application Date: 2022-04-27
-
Publication No.: US11918558B2Publication Date: 2024-03-05
- Inventor: Thomas Jorg Mehrling , Marco Herling
- Applicant: Purdue Pharma L.P.
- Applicant Address: US CT Stamford
- Assignee: Purdue Pharma L.P.
- Current Assignee: Purdue Pharma L.P.
- Current Assignee Address: US CT Stamford
- Agency: McCarter & English, LLP
- Agent Yu Lu
- Priority: GB 09402 2017.06.13
- Main IPC: A61K31/4184
- IPC: A61K31/4184 ; A61K9/00 ; A61P35/02
Abstract:
T-PLL Therapy There is provided tinostamustine or a pharmaceutically acceptable salt thereof for use in the treatment of T-cell prolymphocytic leukemia (T-PLL) in a patient in need thereof.
Public/Granted literature
- US20220401417A1 TINOSTAMUSTINE FOR USE IN THE TREATMENT OF T-CELL PROLYMPHOCYTIC LEUKAEMIA Public/Granted day:2022-12-22
Information query
IPC分类:
